Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Angiotech extends study of micellar paclitaxel as treatment of severe psoriasis

Nov. 21, 2001

International expansion of Celgene's Thalomid accelerated through recent agreements

Nov. 21, 2001

Inhibitors of P-450RAI as an approach to psoriasis and other retinoid-responsive disorders

Nov. 20, 2001

E.U. approval of Protopic recommended by CPMP

Nov. 20, 2001

Interim results show OrCel's efficacy and speed in healing diabetic ulcers

Nov. 19, 2001

Novel compounds described in recent patent as chemokine IL-8 antagonists

Nov. 9, 2001

Chemokine IL-8 receptor antagonists claimed by GSK scientists

Nov. 8, 2001

Positive phase IV results reported for Olux in mild to moderate body psoriasis

Nov. 8, 2001

Positive preliminary data obtained for frozen OrCel in Rx of venous leg ulcers

Nov. 8, 2001

New chemokine IL-8 receptor antagonists under study at GSK

Nov. 2, 2001

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026